Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?
Keith GomezMichael A LaffanCharlotte Ann BradburyPublished in: British journal of haematology (2020)